UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a Curling Stone Delivery Robot with High Delivery Reproducibility

Journal of robotics and mechatronics, 2024-08, Vol.36 (4), p.864-870

2024

Volltextzugriff (PDF)

Development environment for digital curling and implementation of a curler client in Python

The Proceedings of the Symposium on sports and human dynamics, 2023, Vol.2023, p.B-4-2

2023

Volltextzugriff (PDF)

Research on Position Estimation of Curling Stones Around House by Mobile Robot

The Proceedings of the Symposium on sports and human dynamics, 2023, Vol.2023, p.B-4-3

2023

Volltextzugriff (PDF)

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Clinical cancer research, 2009-11, Vol.15 (21), p.6630-6638

2009

Volltextzugriff (PDF)

Genetically engineered humanized anti‐ganglioside GM2 antibody against multiple organ metastasis produced by GM2‐expressing small‐cell lung cancer cells

Cancer science, 2011-12, Vol.102 (12), p.2157-2163

2011

Volltextzugriff (PDF)

Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

Clinical cancer research, 2010-01, Vol.16 (1), p.174-183

2010

Volltextzugriff (PDF)

Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer

The American journal of pathology, 2012-09, Vol.181 (3), p.1034-1043

2012

Volltextzugriff (PDF)

Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network

The American journal of pathology, 2011-09, Vol.179 (3), p.1483-1493

2011

Volltextzugriff (PDF)

E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles

Clinical cancer research, 2009-12, Vol.15 (23), p.7229-7237

2009

Volltextzugriff (PDF)

Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor―Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer

Clinical cancer research, 2012-03, Vol.18 (6), p.1663-1671

2012

Volltextzugriff (PDF)

Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Clinical cancer research, 2011-04, Vol.17 (8), p.2260-2269

2011

Volltextzugriff (PDF)

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations

Oncogene, 2013-09, Vol.32 (37), p.4427-4435

2013

Volltextzugriff (PDF)

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2

Cancer science, 2008-08, Vol.99 (8), p.1603-1610

2008

Volltextzugriff (PDF)

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice

Molecular cancer therapeutics, 2009-01, Vol.8 (1), p.119-126

2009

Volltextzugriff (PDF)

E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor

Molecular cancer therapeutics, 2011-07, Vol.10 (7), p.1218-1228

2011

Volltextzugriff (PDF)

Abstract 629: Hepatocyte growth factor induces resistance to an irreversible epidermal growth factor receptor inhibitor in EGFR -T790M mutant lung cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.629-629

2010

Volltextzugriff (PDF)

Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement

Cancer letters, 2008-06, Vol.265 (1), p.55-66

2008

Volltextzugriff (PDF)

Antiangiogenic therapies for malignant pleural mesothelioma

Frontiers in bioscience, 2011-01, Vol.16 (2), p.740-748

2011

Volltextzugriff (PDF)

Abstract 626: Therapeutic effect of HGF inhibitors against HGF-induced EGFR-TKI resistance in lung cancer harboring EGFR mutations

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.626-626

2010

Volltextzugriff (PDF)

Measurement of aortic diameters and detection of asymptomatic aortic aneurysms in a mass screening program using a mobile helical computed tomography unit

Heart and vessels, 2002-01, Vol.16 (2), p.42-45

2002

Volltextzugriff (PDF)

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Current signal transduction therapy, 2011-05, Vol.6 (2), p.228-233

2011

Volltextzugriff (PDF)

Abstract A178: Role of tumor and host-derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation-positive lung cancer

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A178-A178

2009

Volltextzugriff (PDF)

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA 1 and LPA 2

Cancer science, 2008-08, Vol.99 (8), p.1603-1610

2008

Volltextzugriff (PDF)

Sympathetic outflow to the skeletal muscle in humans increases during prolonged light exercise

Journal of applied physiology (1985), 1997-04, Vol.82 (4), p.1237-1243

1997

Volltextzugriff (PDF)

A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice

Oncology research, 2009-01, Vol.17 (11-12), p.581-591

2009

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(17)
Life Sciences & Biomedicine
(17)
Cell Line, Tumor
(14)
Animals
(13)
Mice
(13)
Mice, Scid
(11)
Oncology
(11)
Biological And Medical Sciences
(10)
Male
(9)
Medical Sciences
(9)
Pneumology
(8)
Tumors Of The Respiratory System And Mediastinum
(8)
Cell Proliferation - Drug Effects
(6)
Lung Neoplasms - Drug Therapy
(6)
Lung Neoplasms - Pathology
(6)
Mutation
(6)
Receptor, Epidermal Growth Factor - Genetics
(6)
Female
(5)
Quinazolines - Pharmacology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development of a Curling Stone Delivery Robot with High Delivery Reproducibility

Development environment for digital curling and implementation of a curler client in Python

Research on Position Estimation of Curling Stones Around House by Mobile Robot

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Genetically engineered humanized anti‐ganglioside GM2 antibody against multiple organ metastasis produced by GM2‐expressing small‐cell lung cancer cells

Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer

Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network

E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles

Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor―Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer

Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice

E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor

Abstract 629: Hepatocyte growth factor induces resistance to an irreversible epidermal growth factor receptor inhibitor in EGFR -T790M mutant lung cancer

Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement

Antiangiogenic therapies for malignant pleural mesothelioma

Abstract 626: Therapeutic effect of HGF inhibitors against HGF-induced EGFR-TKI resistance in lung cancer harboring EGFR mutations

Measurement of aortic diameters and detection of asymptomatic aortic aneurysms in a mass screening program using a mobile helical computed tomography unit

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Abstract A178: Role of tumor and host-derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation-positive lung cancer

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA 1 and LPA 2

Sympathetic outflow to the skeletal muscle in humans increases during prolonged light exercise

A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice

Suchergebnisse filtern